Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KNSA
LGND
Add up to 3 more stocks
KNSA
Kiniksa Pharmaceuticals International, plc
+0.51%
$76.70+0.39Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$5.85B
52W Range
$35.20 - $82.94
LGND
Ligand Pharmaceuticals Incorporated
-3.61%
$295.70-11.07Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$5.93B
52W Range
$175.89 - $326.63
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 78.27 | 31.63 |
| Forward P/E | 55.07 | 31.78 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 8.94 | 6.13 |
| P/S Ratio | 6.95 | 20.40 |
| P/FCF Ratio | 31.92 | 45.11 |
| EV/EBITDA | 55.65 | 44.83 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 54.5% | 98.6% |
| Operating Margin | 11.9% | 17.6% |
| Net Margin | 9.6% | 67.9% |
| ROE | 12.3% | 20.4% |
| ROA | 9.0% | 9.0% |
| ROIC | 9.8% | 3.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.90 | 31.18 |
| Quick Ratio | 3.49 | 30.96 |
| Debt/Equity | 0.01 | 1.17 |
| Interest Coverage | N/A | 10.01 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.